View Report Details Global TAVR Market Report ----------------------------------------2016
View Report Details Executive Summary Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less invasive method of replacing heart valve without undergoing the conventional by-pass surgery. Aortic valve replacement typically requires open heart surgery, thus it disqualifies patients who are at high risk for the process or are too weak to undergo a surgery. As a result, the market of heart valve surgical procedures is witnessing a continuous decline as more and more patients requiring valve replacement are at risk for a surgical treatment. This shortcoming of the traditional surgical method has paved way for the popularity and adoption of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market for TAVR is regarded to be promising with immense growth opportunities and unmet demand to cater to. Rise in economic development, increasing old age population, growing obese population, and increase of aortic stenosis patients are some of the key drivers fueling the development of the global TAVR market. Growth of this market is largely dependent on macro indicators, like global GDP and global healthcare expenditure. This report analyzes the development of "global TAVR market", with special focus on the major markets like the United States and Europe. The major market trends and drivers that facilitate the growth of this market as well as the challenges it is facing are also analyzed in this report. The top players operating in the TAVR industry include Edward Lifesciences, Medtronic and St. Jude Medical and these companies have been profiled in the report highlighting their key financials and business strategies for growth and market expansion.
Growing old age population, rising demand of TAVR procedures are driving the TAVR market.. Global TAVR Market Value and Penetration (2011-2014)
The global TAVR market increased from US$... million in 2011 to US$... million in 2012 and US$... million in 2013 by … % and … % respectively. This further increased by … % to reach US$... million in 2014.
US$ Million
The TAVR market is highly concentrated in the two countries, US and Europe, but soon it is expected to expand its reach in AsiaPacific and Middle East region as well. As of 2014, the US accounted for ….% of the global market share while the rest of the world contributed for …..% of the market share.
2011
2012
2013
2014
TAVR is the most feasible alternative to conventional surgical aortic valve replacement and saw very high adoption rate in the US. The total number of TAVR implants in 2011 was ….which increased by ….% and ….% to reach ….and ….in 2012 and 2013 respectively. This further increased by ……to ……in 2014.
Global TAVR Revenue by Region (2014)
Global Implants Sold (2011-2014)
Chart Title
2011
2012
2013
2014
The growth was primarily driven by US, followed by the rest of the world… The US TAVR Market Value and Penetration-(2011-2014)
In 2011, the US market was worth ….million which increased by ….% and ….% in 2012 and 2013 to reach …million and ….million respectively. This further increased by ….% in 2014 to amount to ….million. This growth is mainly due to rising adoption of minimally invasive (MI) procedures, preference to TAVR by cardiologists, its safety and high efficiency.
US$ Million
The TAVR market outside US increased from ….million in 2011 to ….million in 2012 and ….million in 2013 by ….% and ….% respectively. This further increased by …% to amount to ….million in 2014. This growth in revenue is mainly attributed to benefits of TAVR procedure such as low risk of infection, minimal blood loss, reduced need for blood transfusions, reduction in hospital stays, less pain and scarring, and faster healing.
2011
2012
2013
2014
Total TAVR products sold in 2011 was ….and …. in 2012. This further increased by …% and …..% to reach …. and …. in 2013 and 2014 respectively.
The OUS TAVR Market Value and Penetration-(2011-2014)
US$ Million
Total Implants Sold in European Union (2011-2014)
2011
2012
2013
2014
2011
2012
2013
2014
Rising expense in healthcare expenditure and global GDP will drive the TAVR market…
US$ Million
Global TAVR Market Value (2015-2019)
2015
2016
2017
2018
2019
Economic growth worldwide, rising income and wealth levels, increasing ageing population and continuously increasing obese population are some of the major factors which are expected to fuel the growth of TAVR revenue in the US. US TAVR market is forecasted to grow from ….million in 2015 to amount to ….million in 2019. The future growth of TAVR market would mainly be driven by increasing obese population, increase healthcare expenses and increase in global GDP.
Contact Us: Details View Report These are abridged and sanitized sample pages from the comprehensive report on the “ Global TAVR Market ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com